Impact of Early Coronary Artery Bypass Graft in an Unselected Acute Coronary Syndrome Patient Population
Authors:
- Pedro MonteiroPMPedro Monteiro
- Portuguese Registry On Acute Coronary SyndromesPSPortuguese Registry On Acute Coronary Syndromes
- 4 July 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 114 (1_suppleme) , I-467-I-472
Abstract
Background— Performance of coronary artery bypass graft (CABG) during an acute coronary syndrome (ACS) is mainly used in high-risk patients. Although potentially life-saving, patients undergoing early CABG are traditionally associated with a worse outcome than those not requiring CABG. Is this really true in an unselected ACS population? The aim of this study was to evaluate, in an ACS population, if the performance of CABG during the index hospitalization influences in-hospital outcome. Methods and Results— Retrospective analysis of a nationwide database of 12 988 ACS patients admitted since 2002. Of those, 267 patients underwent CABG during the index hospitalization (group A) and 12 721 did not (group B). Group B patients were further divided in 2 subgroups: those submitted to percutaneous coronary interventions (PCI) (group B 1 ; n=3948) during the index hospitalization and those not submitted to mechanical revascularization (group B 2 ; n =8773). Patients from group A more frequently had diabetes, hypercholesterolemia, hypertension, and previous angina; they were also more often on cardiovascular medication before admission. Patients that underwent CABG were more often in Killip class IV at admission (4.8% versus 1.4% versus 2.0%); they also received more nitrates and catecholamines. Left ventricular function was better in group B 1 . Group A patients were more often on mechanical ventilation and intra-aortic pump and they had more in-hospital complications (31.1% versus 18.7% versus 17.3%), namely recurrent angina, re-infarction, and mechanical complications. They had a more severe coronary anatomy and the culprit lesion was more frequently on the left main (7.7% versus 0.5% versus 2.2%). However, their in-hospital mortality was significantly lower (1.1% versus 2.2% versus 6.8%; P Conclusions— In unselected patients admitted for ACS, performance of early CABG, despite being performed in higher-risk patients, is associated with very low in-hospital mortality, even when compared with the mortality of lower-risk population not submitted to early CABG. Therefore, early performance of this procedure should be considered more often in eligible patients.Keywords
This publication has 12 references indexed in Scilit:
- Differences in the Management and Prognosis of Women and Men Who Suffer From Acute Coronary SyndromesJACC, 2005
- Utilization of catheterization and revascularization procedures in patients with non-ST segment elevation acute coronary syndrome over the last decadeCatheterization and Cardiovascular Interventions, 2005
- The impact of acute coronary syndrome on clinical, economic, and cardiac-specific health status after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: 1-year results from the stent or surgery (SoS) trialAmerican Heart Journal, 2005
- Magnitude of and Risk Factors for In-Hospital and Postdischarge Stroke in Patients With Acute Coronary SyndromesCirculation, 2005
- Utilization of Early Invasive Management Strategies for High-Risk Patients With Non–ST-Segment Elevation Acute Coronary SyndromesJAMA, 2004
- The Outcome of Coronary Artery Bypass Grafting Surgery among Patients Hospitalized with Acute Coronary Syndrome: The Euro Heart Survey of Acute Coronary Syndrome ExperienceCardiology, 2004
- Association of revascularisation with low mortality in non-ST elevation acute coronary syndrome, a report from GUSTO IV-ACSEuropean Heart Journal, 2004
- Management of acute coronary syndromes in patients presenting without persistent ST-segment elevationEuropean Heart Journal, 2002
- Comparison of Early Invasive and Conservative Strategies in Patients with Unstable Coronary Syndromes Treated with the Glycoprotein IIb/IIIa Inhibitor TirofibanNew England Journal of Medicine, 2001
- Myocardial infarction redefined—A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial InfarctionEuropean Heart Journal, 2000